Invention Grant
- Patent Title: Use of IκB-kinase inhibitors in pain therapy
- Patent Title (中): 使用I＆kgr; B激酶抑制剂治疗疼痛
-
Application No.: US12266018Application Date: 2008-11-06
-
Publication No.: US08809358B2Publication Date: 2014-08-19
- Inventor: Martin Michaelis , Olaf Ritzeler , Gerhard Jaehne , Karl Rudolphi , Gerd Geisslinger , Hans-Georg Schaible
- Applicant: Martin Michaelis , Olaf Ritzeler , Gerhard Jaehne , Karl Rudolphi , Gerd Geisslinger , Hans-Georg Schaible
- Applicant Address: DE Frankfurt am Main
- Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee: Sanofi-Aventis Deutschland GmbH
- Current Assignee Address: DE Frankfurt am Main
- Agent Kelly L. Bender
- Priority: DE10237723 20020817
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K31/44 ; A61K31/4152
Abstract:
The present invention relates to the use of IκB-kinase Inhibitors and methods for the prophylaxis and therapy for treating pain comprising administering such compounds.
Public/Granted literature
- US20090069358A1 Use of IKappaB-Kinase Inhibitors in Pain Therapy Public/Granted day:2009-03-12
Information query
IPC分类:
